Global Chronic Kidney Disease (CKD) Market Growth (Status and Outlook) 2024-2030

2024

Global Chronic Kidney Disease (CKD) Market Growth (Status and Outlook) 2024-2030

Name: Global Chronic Kidney Disease (CKD) Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001431
Price: 3450 USD
Availability: InStock
Rating: 4 (9.6 reviews)

The global Chronic Kidney Disease (CKD) market was valued at US$ 86.6 billion in 2023, with growing demand for treatments and healthcare services.

Bonafide Trust
09-09-2024
Pages : 109
Figures : 77
Tables : 117
Region : Global
Category : Lifescience & Healthcare
Healthcare

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global chronic kidney disease (CKD) market is a rapidly evolving segment within the healthcare industry, driven by the increasing prevalence of CKD and the growing awareness of its associated health risks. CKD, characterized by the gradual loss of kidney function over time, affects millions of people worldwide and is often linked to conditions such as diabetes, hypertension, and obesity. The market encompasses a wide range of diagnostic and therapeutic products, including blood tests, urine tests, imaging studies, medications, dialysis, and kidney transplants. Advances in medical technology and research have led to the development of more accurate diagnostic tools and innovative treatment options, improving patient outcomes and quality of life. The market is also influenced by demographic changes, with aging populations and rising incidences of chronic diseases contributing to the growing demand for CKD management solutions. Additionally, healthcare policies and reimbursement scenarios play a crucial role in shaping the market dynamics, as governments and insurance providers strive to address the burden of CKD through improved access to care and cost-effective treatments. The global CKD market is expected to continue its upward trajectory, driven by ongoing research, technological advancements, and the increasing focus on preventive healthcare measures. The research report highlights the growth potential of the global Chronic Kidney Disease (CKD) market. Chronic Kidney Disease (CKD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Chronic Kidney Disease (CKD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Chronic Kidney Disease (CKD) market.

According to Publisher, the global chronic kidney disease (CKD) market size was valued at US$ 86610 million in 2023. With growing demand in downstream market, the chronic kidney disease (CKD) is forecast to a readjusted size of US$ 109860 million by 2030 with a CAGR of 3.5% during review period. The global chronic kidney disease (CKD) market is driven by several key factors, including the increasing prevalence of CKD, rising awareness about kidney health, advancements in diagnostic and treatment options, and government initiatives to improve healthcare infrastructure. CKD is often associated with chronic conditions such as diabetes and hypertension, which are becoming more prevalent due to lifestyle changes and aging populations. This has led to a higher demand for diagnostic tests and treatments, including blood tests, urine tests, imaging studies, medications, dialysis, and kidney transplants. Technological advancements in medical devices and pharmaceuticals have improved the accuracy and effectiveness of CKD management, enhancing patient outcomes and quality of life. Additionally, government policies and healthcare programs aimed at improving access to CKD care and promoting preventive measures are contributing to market growth. The increasing focus on telemedicine and home healthcare solutions is also driving the adoption of CKD management practices, making it easier for patients to receive timely and convenient care. These market drivers collectively support the expansion of the global CKD market, addressing the growing healthcare needs of CKD patients worldwide. Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory condition characterized by persistent airflow limitation that makes it difficult to breathe. COPD encompasses a group of diseases, with the most common being emphysema and chronic bronchitis

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global Chronic Kidney Disease (CKD) market is segmented by type into diagnostics, therapeutics, and dialysis. The diagnostics segment includes blood tests, urine tests, imaging studies, and genetic testing, which are essential for early detection and monitoring of CKD. These diagnostic tools help in identifying the presence of kidney damage and assessing the severity of the disease. The therapeutics segment comprises medications such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and other drugs that manage symptoms and slow disease progression. Additionally, this segment includes novel therapies and biologics that target specific pathways involved in CKD. The dialysis segment involves both hemodialysis and peritoneal dialysis, which are critical for patients with end-stage renal disease (ESRD). Hemodialysis uses a machine to filter waste products and excess fluids from the blood, while peritoneal dialysis uses the lining of the abdomen to perform the filtration process. Each type of CKD management plays a crucial role in improving patient outcomes and quality of life, addressing the diverse needs of CKD patients, and driving innovation and growth in the global market.

The global chronic kidney disease (CKD) market is segmented by application into diagnostics, therapeutics, and dialysis. The diagnostics segment includes blood tests, urine tests, imaging studies, and genetic testing, which are essential for early detection and monitoring of CKD. These diagnostic tools help in identifying the presence of kidney damage and assessing the severity of the disease. The therapeutics segment comprises medications such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and other drugs that manage symptoms and slow disease progression. Additionally, this segment includes novel therapies and biologics that target specific pathways involved in CKD. The dialysis segment involves both hemodialysis and peritoneal dialysis, which are critical for patients with end-stage renal disease (ESRD). Hemodialysis uses a machine to filter waste products and excess fluids from the blood, while peritoneal dialysis uses the lining of the abdomen to perform the filtration process. Each type of CKD management plays a crucial role in improving patient outcomes and quality of life, addressing the diverse needs of CKD patients, and driving innovation and growth in the global market.

The regional analysis of the global chronic kidney disease (CKD) market reveals significant variability in disease burden and healthcare infrastructure across different regions. The Asia-Pacific region is experiencing a rapid increase in CKD cases due to rising incidences of diabetes and hypertension, coupled with aging populations. Countries like China and India are witnessing a surge in CKD prevalence, prompting governments to invest in healthcare infrastructure and CKD management programs. The North American region has a well-established CKD management framework, with advanced diagnostic and treatment options available to patients. However, the high cost of CKD treatments remains a challenge, leading to disparities in access to care. The European region focuses on preventive healthcare measures and early intervention strategies to manage CKD effectively. Countries like Germany and the United Kingdom have implemented comprehensive CKD screening programs and public health campaigns to raise awareness about kidney health. The Middle East and Africa regions face significant challenges in CKD management due to limited healthcare resources and infrastructure. Efforts are being made to improve access to diagnostic tools and treatments, with international organizations providing support to enhance CKD care in these regions. Each region presents unique opportunities and challenges, with regional players adapting to local market conditions and regulatory environments to drive growth and innovation in the global CKD market

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chronic Kidney Disease (CKD) Market Size 2019-2030
2.1.2 Chronic Kidney Disease (CKD) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Chronic Kidney Disease (CKD) Segment by Type
2.2.1 ACE Inhibitors
2.2.2 Calcium Channel Blockers
2.2.3 Beta Blockers
2.2.4 Others
2.3 Chronic Kidney Disease (CKD) Market Size by Type
2.3.1 Chronic Kidney Disease (CKD) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Chronic Kidney Disease (CKD) Market Size Market Share by Type (2019-2024)
2.4 Chronic Kidney Disease (CKD) Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.5 Chronic Kidney Disease (CKD) Market Size by Application
2.5.1 Chronic Kidney Disease (CKD) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Chronic Kidney Disease (CKD) Market Size Market Share by Application (2019-2024)
3 Chronic Kidney Disease (CKD) Market Size by Player
3.1 Chronic Kidney Disease (CKD) Market Size Market Share by Players
3.1.1 Global Chronic Kidney Disease (CKD) Revenue by Players (2019-2024)
3.1.2 Global Chronic Kidney Disease (CKD) Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Kidney Disease (CKD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Chronic Kidney Disease (CKD) by Regions
4.1 Chronic Kidney Disease (CKD) Market Size by Regions (2019-2024)
4.2 Americas Chronic Kidney Disease (CKD) Market Size Growth (2019-2024)
4.3 APAC Chronic Kidney Disease (CKD) Market Size Growth (2019-2024)
4.4 Europe Chronic Kidney Disease (CKD) Market Size Growth (2019-2024)
4.5 Middle East & Africa Chronic Kidney Disease (CKD) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Chronic Kidney Disease (CKD) Market Size by Country (2019-2024)
5.2 Americas Chronic Kidney Disease (CKD) Market Size by Type (2019-2024)
5.3 Americas Chronic Kidney Disease (CKD) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Kidney Disease (CKD) Market Size by Region (2019-2024)
6.2 APAC Chronic Kidney Disease (CKD) Market Size by Type (2019-2024)
6.3 APAC Chronic Kidney Disease (CKD) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Chronic Kidney Disease (CKD) by Country (2019-2024)
7.2 Europe Chronic Kidney Disease (CKD) Market Size by Type (2019-2024)
7.3 Europe Chronic Kidney Disease (CKD) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chronic Kidney Disease (CKD) by Region (2019-2024)
8.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2019-2024)
8.3 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Chronic Kidney Disease (CKD) Market Forecast
10.1 Global Chronic Kidney Disease (CKD) Forecast by Regions (2025-2030)
10.1.1 Global Chronic Kidney Disease (CKD) Forecast by Regions (2025-2030)
10.1.2 Americas Chronic Kidney Disease (CKD) Forecast
10.1.3 APAC Chronic Kidney Disease (CKD) Forecast
10.1.4 Europe Chronic Kidney Disease (CKD) Forecast
10.1.5 Middle East & Africa Chronic Kidney Disease (CKD) Forecast
10.2 Americas Chronic Kidney Disease (CKD) Forecast by Country (2025-2030)
10.2.1 United States Chronic Kidney Disease (CKD) Market Forecast
10.2.2 Canada Chronic Kidney Disease (CKD) Market Forecast
10.2.3 Mexico Chronic Kidney Disease (CKD) Market Forecast
10.2.4 Brazil Chronic Kidney Disease (CKD) Market Forecast
10.3 APAC Chronic Kidney Disease (CKD) Forecast by Region (2025-2030)
10.3.1 China Chronic Kidney Disease (CKD) Market Forecast
10.3.2 Japan Chronic Kidney Disease (CKD) Market Forecast
10.3.3 Korea Chronic Kidney Disease (CKD) Market Forecast
10.3.4 Southeast Asia Chronic Kidney Disease (CKD) Market Forecast
10.3.5 India Chronic Kidney Disease (CKD) Market Forecast
10.3.6 Australia Chronic Kidney Disease (CKD) Market Forecast
10.4 Europe Chronic Kidney Disease (CKD) Forecast by Country (2025-2030)
10.4.1 Germany Chronic Kidney Disease (CKD) Market Forecast
10.4.2 France Chronic Kidney Disease (CKD) Market Forecast
10.4.3 UK Chronic Kidney Disease (CKD) Market Forecast
10.4.4 Italy Chronic Kidney Disease (CKD) Market Forecast
10.4.5 Russia Chronic Kidney Disease (CKD) Market Forecast
10.5 Middle East & Africa Chronic Kidney Disease (CKD) Forecast by Region (2025-2030)
10.5.1 Egypt Chronic Kidney Disease (CKD) Market Forecast
10.5.2 South Africa Chronic Kidney Disease (CKD) Market Forecast
10.5.3 Israel Chronic Kidney Disease (CKD) Market Forecast
10.5.4 Turkey Chronic Kidney Disease (CKD) Market Forecast
10.5.5 GCC Countries Chronic Kidney Disease (CKD) Market Forecast
10.6 Global Chronic Kidney Disease (CKD) Forecast by Type (2025-2030)
10.7 Global Chronic Kidney Disease (CKD) Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Chronic Kidney Disease (CKD) Product Offered
11.1.3 AbbVie Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Chronic Kidney Disease (CKD) Product Offered
11.2.3 Allergan Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Amgen
11.3.1 Amgen Company Information
11.3.2 Amgen Chronic Kidney Disease (CKD) Product Offered
11.3.3 Amgen Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Amgen Main Business Overview
11.3.5 Amgen Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Chronic Kidney Disease (CKD) Product Offered
11.4.3 AstraZeneca Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Chronic Kidney Disease (CKD) Product Offered
11.5.3 Roche Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 FibroGen
11.6.1 FibroGen Company Information
11.6.2 FibroGen Chronic Kidney Disease (CKD) Product Offered
11.6.3 FibroGen Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 FibroGen Main Business Overview
11.6.5 FibroGen Latest Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Information
11.7.2 GlaxoSmithKline Chronic Kidney Disease (CKD) Product Offered
11.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GlaxoSmithKline Main Business Overview
11.7.5 GlaxoSmithKline Latest Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Information
11.8.2 Johnson & Johnson Chronic Kidney Disease (CKD) Product Offered
11.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Johnson & Johnson Main Business Overview
11.8.5 Johnson & Johnson Latest Developments
11.9 Keryx
11.9.1 Keryx Company Information
11.9.2 Keryx Chronic Kidney Disease (CKD) Product Offered
11.9.3 Keryx Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Keryx Main Business Overview
11.9.5 Keryx Latest Developments
11.10 Kissei
11.10.1 Kissei Company Information
11.10.2 Kissei Chronic Kidney Disease (CKD) Product Offered
11.10.3 Kissei Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Kissei Main Business Overview
11.10.5 Kissei Latest Developments
11.11 Pfizer
11.11.1 Pfizer Company Information
11.11.2 Pfizer Chronic Kidney Disease (CKD) Product Offered
11.11.3 Pfizer Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Pfizer Main Business Overview
11.11.5 Pfizer Latest Developments
11.12 Sanofi
11.12.1 Sanofi Company Information
11.12.2 Sanofi Chronic Kidney Disease (CKD) Product Offered
11.12.3 Sanofi Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sanofi Main Business Overview
11.12.5 Sanofi Latest Developments
11.13 Teva
11.13.1 Teva Company Information
11.13.2 Teva Chronic Kidney Disease (CKD) Product Offered
11.13.3 Teva Chronic Kidney Disease (CKD) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Teva Main Business Overview
11.13.5 Teva Latest Developments
12 Research Findings and Conclusion

Table 1. Chronic Kidney Disease (CKD) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of ACE Inhibitors
Table 3. Major Players of Calcium Channel Blockers
Table 4. Major Players of Beta Blockers
Table 5. Major Players of Others
Table 6. Chronic Kidney Disease (CKD) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Chronic Kidney Disease (CKD) Market Size Market Share by Type (2019-2024)
Table 9. Chronic Kidney Disease (CKD) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Chronic Kidney Disease (CKD) Market Size Market Share by Application (2019-2024)
Table 12. Global Chronic Kidney Disease (CKD) Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Chronic Kidney Disease (CKD) Revenue Market Share by Player (2019-2024)
Table 14. Chronic Kidney Disease (CKD) Key Players Head office and Products Offered
Table 15. Chronic Kidney Disease (CKD) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Chronic Kidney Disease (CKD) Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Chronic Kidney Disease (CKD) Market Size Market Share by Regions (2019-2024)
Table 20. Global Chronic Kidney Disease (CKD) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Chronic Kidney Disease (CKD) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Chronic Kidney Disease (CKD) Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Chronic Kidney Disease (CKD) Market Size Market Share by Country (2019-2024)
Table 24. Americas Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Chronic Kidney Disease (CKD) Market Size Market Share by Type (2019-2024)
Table 26. Americas Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Chronic Kidney Disease (CKD) Market Size Market Share by Application (2019-2024)
Table 28. APAC Chronic Kidney Disease (CKD) Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Chronic Kidney Disease (CKD) Market Size Market Share by Region (2019-2024)
Table 30. APAC Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Chronic Kidney Disease (CKD) Market Size Market Share by Type (2019-2024)
Table 32. APAC Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Chronic Kidney Disease (CKD) Market Size Market Share by Application (2019-2024)
Table 34. Europe Chronic Kidney Disease (CKD) Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Chronic Kidney Disease (CKD) Market Size Market Share by Country (2019-2024)
Table 36. Europe Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Chronic Kidney Disease (CKD) Market Size Market Share by Type (2019-2024)
Table 38. Europe Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Chronic Kidney Disease (CKD) Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Chronic Kidney Disease (CKD) Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Chronic Kidney Disease (CKD) Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Chronic Kidney Disease (CKD) Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Chronic Kidney Disease (CKD)
Table 47. Key Market Challenges & Risks of Chronic Kidney Disease (CKD)
Table 48. Key Industry Trends of Chronic Kidney Disease (CKD)
Table 49. Global Chronic Kidney Disease (CKD) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Chronic Kidney Disease (CKD) Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Chronic Kidney Disease (CKD) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Chronic Kidney Disease (CKD) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. AbbVie Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 54. AbbVie Chronic Kidney Disease (CKD) Product Offered
Table 55. AbbVie Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Allergan Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 59. Allergan Chronic Kidney Disease (CKD) Product Offered
Table 60. Allergan Main Business
Table 61. Allergan Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Allergan Latest Developments
Table 63. Amgen Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 64. Amgen Chronic Kidney Disease (CKD) Product Offered
Table 65. Amgen Main Business
Table 66. Amgen Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Amgen Latest Developments
Table 68. AstraZeneca Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 69. AstraZeneca Chronic Kidney Disease (CKD) Product Offered
Table 70. AstraZeneca Main Business
Table 71. AstraZeneca Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. AstraZeneca Latest Developments
Table 73. Roche Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 74. Roche Chronic Kidney Disease (CKD) Product Offered
Table 75. Roche Main Business
Table 76. Roche Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Roche Latest Developments
Table 78. FibroGen Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 79. FibroGen Chronic Kidney Disease (CKD) Product Offered
Table 80. FibroGen Main Business
Table 81. FibroGen Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. FibroGen Latest Developments
Table 83. GlaxoSmithKline Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 84. GlaxoSmithKline Chronic Kidney Disease (CKD) Product Offered
Table 85. GlaxoSmithKline Main Business
Table 86. GlaxoSmithKline Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. GlaxoSmithKline Latest Developments
Table 88. Johnson & Johnson Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 89. Johnson & Johnson Chronic Kidney Disease (CKD) Product Offered
Table 90. Johnson & Johnson Main Business
Table 91. Johnson & Johnson Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Johnson & Johnson Latest Developments
Table 93. Keryx Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 94. Keryx Chronic Kidney Disease (CKD) Product Offered
Table 95. Keryx Main Business
Table 96. Keryx Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Keryx Latest Developments
Table 98. Kissei Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 99. Kissei Chronic Kidney Disease (CKD) Product Offered
Table 100. Kissei Main Business
Table 101. Kissei Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Kissei Latest Developments
Table 103. Pfizer Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 104. Pfizer Chronic Kidney Disease (CKD) Product Offered
Table 105. Pfizer Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Sanofi Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 109. Sanofi Chronic Kidney Disease (CKD) Product Offered
Table 110. Sanofi Main Business
Table 111. Sanofi Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Sanofi Latest Developments
Table 113. Teva Details, Company Type, Chronic Kidney Disease (CKD) Area Served and Its Competitors
Table 114. Teva Chronic Kidney Disease (CKD) Product Offered
Table 115. Teva Main Business
Table 116. Teva Chronic Kidney Disease (CKD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Teva Latest Developments
List of

Figure 1. Chronic Kidney Disease (CKD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chronic Kidney Disease (CKD) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Chronic Kidney Disease (CKD) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Chronic Kidney Disease (CKD) Sales Market Share by Country/Region (2023)
Figure 8. Chronic Kidney Disease (CKD) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Chronic Kidney Disease (CKD) Market Size Market Share by Type in 2023
Figure 10. Chronic Kidney Disease (CKD) in Hospitals
Figure 11. Global Chronic Kidney Disease (CKD) Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Chronic Kidney Disease (CKD) in Specialty Clinics
Figure 13. Global Chronic Kidney Disease (CKD) Market: Specialty Clinics (2019-2024) & ($ Millions)
Figure 14. Global Chronic Kidney Disease (CKD) Market Size Market Share by Application in 2023
Figure 15. Global Chronic Kidney Disease (CKD) Revenue Market Share by Player in 2023
Figure 16. Global Chronic Kidney Disease (CKD) Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Chronic Kidney Disease (CKD) Market Size 2019-2024 ($ Millions)
Figure 18. APAC Chronic Kidney Disease (CKD) Market Size 2019-2024 ($ Millions)
Figure 19. Europe Chronic Kidney Disease (CKD) Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Chronic Kidney Disease (CKD) Market Size 2019-2024 ($ Millions)
Figure 21. Americas Chronic Kidney Disease (CKD) Value Market Share by Country in 2023
Figure 22. United States Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Chronic Kidney Disease (CKD) Market Size Market Share by Region in 2023
Figure 27. APAC Chronic Kidney Disease (CKD) Market Size Market Share by Type in 2023
Figure 28. APAC Chronic Kidney Disease (CKD) Market Size Market Share by Application in 2023
Figure 29. China Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Chronic Kidney Disease (CKD) Market Size Market Share by Country in 2023
Figure 36. Europe Chronic Kidney Disease (CKD) Market Size Market Share by Type (2019-2024)
Figure 37. Europe Chronic Kidney Disease (CKD) Market Size Market Share by Application (2019-2024)
Figure 38. Germany Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Chronic Kidney Disease (CKD) Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Chronic Kidney Disease (CKD) Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Chronic Kidney Disease (CKD) Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Chronic Kidney Disease (CKD) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 52. APAC Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 53. Europe Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 55. United States Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 56. Canada Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 59. China Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 60. Japan Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 61. Korea Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 63. India Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 64. Australia Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 65. Germany Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 66. France Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 67. UK Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 68. Italy Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 69. Russia Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 70. Spain Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 73. Israel Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Chronic Kidney Disease (CKD) Market Size 2025-2030 ($ Millions)
Figure 76. Global Chronic Kidney Disease (CKD) Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Chronic Kidney Disease (CKD) Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted